Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 16:48
Organogenesis Holdings Market Cap: 530.30M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 587.31M |
| November 12, 2024 | 457.38M |
| November 11, 2024 | 464.01M |
| November 08, 2024 | 434.85M |
| November 07, 2024 | 432.19M |
| November 06, 2024 | 425.57M |
| November 05, 2024 | 403.03M |
| November 04, 2024 | 396.40M |
| November 01, 2024 | 368.56M |
| October 31, 2024 | 367.23M |
| October 30, 2024 | 383.14M |
| October 29, 2024 | 395.07M |
| October 28, 2024 | 391.10M |
| October 25, 2024 | 371.21M |
| October 24, 2024 | 380.49M |
| October 23, 2024 | 383.14M |
| October 22, 2024 | 410.98M |
| October 21, 2024 | 412.31M |
| October 18, 2024 | 418.94M |
| October 17, 2024 | 407.01M |
| October 16, 2024 | 430.87M |
| October 15, 2024 | 424.24M |
| October 14, 2024 | 409.66M |
| October 11, 2024 | 407.01M |
| October 10, 2024 | 384.47M |
| Date | Value |
|---|---|
| October 09, 2024 | 400.38M |
| October 08, 2024 | 396.40M |
| October 07, 2024 | 396.40M |
| October 04, 2024 | 408.33M |
| October 03, 2024 | 379.16M |
| October 02, 2024 | 377.84M |
| October 01, 2024 | 373.86M |
| September 30, 2024 | 379.16M |
| September 27, 2024 | 383.14M |
| September 26, 2024 | 373.86M |
| September 25, 2024 | 367.23M |
| September 24, 2024 | 385.79M |
| September 23, 2024 | 373.86M |
| September 20, 2024 | 375.19M |
| September 19, 2024 | 388.44M |
| September 18, 2024 | 377.84M |
| September 17, 2024 | 385.79M |
| September 16, 2024 | 379.16M |
| September 13, 2024 | 372.54M |
| September 12, 2024 | 346.02M |
| September 11, 2024 | 339.39M |
| September 10, 2024 | 339.39M |
| September 09, 2024 | 336.74M |
| September 06, 2024 | 327.46M |
| September 05, 2024 | 350.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
247.92M
Minimum
Mar 24 2023
2.979B
Maximum
May 03 2021
760.33M
Average
454.86M
Median
Nov 13 2020
Market Cap Benchmarks
| Poseida Therapeutics Inc | 311.80M |
| NovaBay Pharmaceuticals Inc | 3.555M |
| Palatin Technologies Inc | 20.92M |
| iBio Inc | 18.83M |
| Theriva Biologics Inc | 1.372M |
Market Cap Related Metrics
| PS Ratio | 1.183 |
| Price to Book Value | 2.013 |
| Price to Free Cash Flow | 62.27 |
| Price | 4.00 |
| Earnings Yield | -3.36% |
| Operating PE Ratio | 44.81 |
| Normalized PE Ratio | 2610.97 |